Notice ID: 026e778296d24bff9f8dd27fb673af55Combined Synopsis/Solicitation
6505--New - NTX Blood Bank Reagents (Identification/ Antibodies)
Archived on November 5, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- July 8, 2022
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- 257-NETWORK CONTRACT OFFICE 17 (36C257)
- Place of performance
- Department of Veterans Affairs VA North Texas Healthcare System Laboratory 4500 S. Lancaster Rd., Dallas, TX, 75216
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C25722Q0845
- Notice ID
- 026e778296d24bff9f8dd27fb673af55
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number 36C25722Q0845 is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-06. The NAICS Code for this request for quotes is 325413 (1,250 Employees). No set-aside is used for this solicitation. The items being requested are as follows: ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT 0001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 1 POP Begin: 11-01-2022 POP End: 10-31-2023 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 0002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 1 POP Begin: 11-01-2022 POP End: 10-31-2023 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 0003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 1 POP Begin: 11-01-2022 POP End: 10-31-2023 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 1001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 2 POP Begin: 11-01-2023 POP End: 10-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 1002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 2 POP Begin: 11-01-2023 POP End: 10-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 1003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 2 POP Begin: 11-01-2023 POP End: 10-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 2001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 3 POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 2002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 3 POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 2003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 4 POP Begin: 11-01-2024 POP End: 10-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 3001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 4 POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 3002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 4 POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 3003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 4 POP Begin: 11-01-2025 POP End: 10-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 4001 13.00 PG Reagent: Red Cells, 0.8% Resolve Panel C Ordering Period 5 POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 4002 50.00 PG ID-Micro Typing System, Anti IGG Gel Card Ordering Period 5 POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) 4003 12.00 BX ID- Micro Typing System Buffers, MTS Diluent 2, 100mL Ordering Period 5 POP Begin: 11-01-2026 POP End: 10-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals Blood Bank Reagents (Identification and Antibodies) The services being requested are for the reference laboratory testing of patient specimen. Services are to be performed at the VA North Texas Healthcare System, Laboratory, 4500 S. Lancaster Rd., Dallas, TX 75216. The provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition. The provision at 52.212-2, Evaluation-Commercial Items, applies to this acquisition. The evaluation criteria are technical acceptability and price. Under technical includes the ability to provide all of the requested items in accordance with the Statement of Work, provide a letter of authorization (if not the manufacturer) and a description of equal items, and have, at minimum, a Satisfactory past performance rating. Offerors are to provide a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. There are no addenda to this clause. The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. The following clauses cited in this clause are applicable: FAR 52.203-19 Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017) FAR 52.204 10, Reporting Executive Compensation and First-Tier Subcontract Awards (JUN 2020) FAR 52.204 23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (Jul 2018) FAR 52.204 25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (AUG 2019) FAR 52.209 6, Protecting the Government s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (NOV 2021) FAR 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (NOV 2015) FAR 52.219 4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (SEP 2021) FAR 52.233-3, Protest After Award (Aug 1996) FAR 52.233-4, Applicable Law for Breach of Contract Claim (Oct 2004) FAR 52.219-28, Post Award Small Business Program Rerepresentation (MAR 2020) FAR 52.222 19, Child Labor Cooperation with Authorities and Remedies (JUL 2020) (DEVIATION) FAR 52.222-21, Prohibition of Segregated Facilities (APR 2015) FAR 52.222 26, Equal Opportunity (SEP 2016) FAR 52.222-36, Equal Opportunity for Workers with Disabilities (JUN 2020) FAR 52.222-50, Combating Trafficking in Persons (JAN 2019) FAR 52.223 18, Encouraging Contractor Policies to Ban Text Messaging While Driving (JUN 2020) FAR 52.225 5, Trade Agreements (JUL 2020) (DEVIATION) FAR 52.225-13, Restrictions on Certain Foreign Purchases (FEB 2021) FAR 52.229 12, Tax on Certain Foreign Procurements (FEB 2021) FAR 52.232-33, Payment by Electronic Funds Transfer System for Award Management (Oct 2018) Additional Terms and Conditions: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (JUL 2016) FAR 52.216-18, Ordering (AUG 2020) FAR 52.216-19, Order Limitations (OCT 1995) FAR 52.216-22, Indefinite Quantity (OCT 1995) FAR 52.217-8, Option to Extend Services (NOV 1999) FAR 52.232-18, Availability of Funds (APR 1984) FAR 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (DEC 2013) FAR 52.317-3, Continuity of Services (JAN 1991) VAAR 852.212-70, Provisions and Clauses Applicable to VA Acquisition of Commercial Items (APR 2020) VAAR 852.203 70, Commercial Advertising VAAR 852.232 72, Electronic Submission of Payment Requests VAAR 852.246-71, Rejected Goods VAAR 852.270 1, Representatives of Contracting Officers VAAR 852.273 70, Late Offers (Provision) VAAR 852.212-71, Gray Market Items (APR 2020) VAAR 852.219-75, Subcontracting Commitments Monitoring and Compliance (JUL 2018) VAAR 852.242-71, Administrative Contracting Officer (OCT 2020) VAAR 852.247-73, Packing for Domestic Shipment (OCT 2018) Additional Provisions: FAR 52.204-7, System for Award Management (OCT 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (AUG 2020) FAR 52.204-24 Representation Regarding Telecommunications and Video Surveillance Services or Equipment (AUG 2019) FAR 52.209-7, Information Regarding Responsibility matters (OCT 2018) FAR 52.211-6, Brand Name or Equal (AUG 1999) FAR 52.214-21, Descriptive Literature (APR 2002) FAR 52.229-11, Tax on Certain Foreign Procurements Notice and Representation (JUN 2020) See attached RFQ document for more information. Late quotes or documentation may be accepted if advantageous to the Government. All comments or inquiries are to be submitted in writing via email to the Point of Contact, referenced above, prior to the closing of the question and answer period, July 20, 2022, at 1:00 p.m. ET. Vendors interested in providing the required supplies will need to submit all required documentation, detailed in the attached RFQ document, to Delphia Schoenfeld at delphia.schoenfeld@va.gov, no later than July 29, 2022, 3 PM ET (2 PM CT).
Award Overview
Possible prior contract
Inferred, not confirmedInferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.
Contract end date
Mar 22, 2021
NAICS
325413
Agency
Department of Veterans Affairs
Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C25722Q0845- Combined Synopsis
- Combined SynopsisCurrentJul 8, 2022
6505--New - NTX Blood Bank Reagents (Identification/ Antibodies)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
NTX blood bank cost per test | 86% | Awarded | Open |
THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice does NOT constitute a request for quote (RFQ), request for proposal (RFP), or invitation for bid (IFB). No solicitation is currently available. This Sources Sought is issued solely for information and planning purposes to conduct market research and determine the availability and capability of qualified sources prior to determining the appropriate acquisition strategy. I. General Information - Agency/Office: Department of Veterans Affairs (VA), VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd. Dallas, TX. 75216 - Place of Performance: VA North Texas Health Care System, Pathology and Laboratory Medicine Service (P&LMS), Microbiology Laboratory, Dallas, Texas. - Anticipated NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing - Anticipated PSC: 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The Government is seeking to identify responsible vendors capable of providing Blood Bank Reagents, used to perform patient manual blood typing and serum antibody detection and identification to be used in the Transfusion Medicine Unit, Pathology and Laboratory Medicine Services at VANTHCS. II. Description of Requirement Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking blood reagents used to perform patient manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. The contemplated purchase includes, at a minimum: The Contractor shall provide reagent supplies as requested by VANTHCS staff to perform blood bank manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. Estimated Yearly Requirements: Item # Description/Part Number* Qty Unit 1 Z401U, ALBAcyte A1 Cells 52 EA 2 Z406U, ALBAcyte A2 Cells 13 EA 3 Z411U, ALBAcyte B Cells 52 EA 4 Z4411U-1, ALBAcyte IgG Sensitized Cells (weak) 26 EA 5 Z473U, ALBAcyte Antibody ID Panel (16-cell) 7 EA 6 Z482U, ALBAcyte C3 Coated Red Blood Cells 13 EA Period of Performance: Base Year: 05/01/2027-04/30/2028 Option Year 1: 05/01/2028-04/30/2029 Option Year 2: 05/01/2029-04/30/2030 Option Year 3: 05/01/2030-04/30/2031 Option Year 4: 05/01/2031-04/30/2032 Location: The manual testing will be performed in Transfusion Medicine Unit, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216. III. Performance requirements: Performance Requirements: The following are required: Packing and Delivery: All Shipping/Freight Charges will be FOB Destination unless noted otherwise by vendor and communicated to the contracting officer prior to award. The reagents shall be delivered at the time specified when the order is placed. The Contractor will furnish appropriate containers for shipment of the reagents. Vendor must be approved by the FDA and shall provide documentation of approval. Vendor must have a defined Quality plan, and Adequate supplies available. IV. Submission Instructions Interested and capable vendors should submit an electronic capability statement and include the place of manufacture for all reagents listed in the sources sought via email in PDF or Word format by November 5, 2026, by 9:00 AM Central Standard Time. - Teresa Arzola  - Email: Teresa.arzola@va.gov  - Subject line: Sources Sought Blood Bank Reagents VA North Texas HCS  No telephone inquiries will be accepted. Responses received will be used solely for market research and planning purposes to assist the Government in determining an appropriate acquisition strategy (e.g., small business set aside or unrestricted). Submission of a capability statement is voluntary and shall not be construed as a commitment by the Government to issue a solicitation or award a contract, nor will the Government pay for information submitted in response to this Sources Sought. | 86% | Market Research | 11/05/2026 |
See Attached: | 71% | Combined Synopsis | 11/16/2026 |
The following VISN 12 Locations have a need for delivery of Blood and Blood Products. Jesse Brown VAMC, 820 South Damen Ave, Chicago, IL 60612 Lovell Federal Health Care Center, 3001 Green Bay Road, North Chicago, IL 60064 Hines VAMC, 5000 South 5th Ave, Hines, IL 60141 William S Middleton VAMC, 2500 Overlook Terrace, Madison, WI 53705. Tomah VAMC, 500 E. Veterans Street, Tomah, WI 54660 Zablocki VAMC, 5000 W. National Ave, Milwaukee WI 53295. The Blood and Blood Products will be defined in RFQ# 36C25226Q0606. | 70% | Awarded | Open |
BD Micro Reagents and Service | 70% | Awarded | Open |
Additional Details
Solicitation Number
36C25722Q0845
Archive Date
Nov 5, 2022
Office Address
San Antonio, TX, 78240